FundingWatcher
Home / Investors / Venture investors / Venture investors in Cambridge, Massachusetts

Venture investors in Cambridge, Massachusetts

Updated 16 Nov 2026

Reset

Venture funds

5 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Founder Collective
Founder Collective backs seed-stage startups, with recent investments including Baselayer, WHOOP and Ownwell.
Cambridge, United States
Artificial intelligence, Commerce Seed, Early stage venture, Late stage venture 6% 5
2 Mission BioCapital
Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio.
Cambridge, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 20% 4
3 F-Prime
F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics.
Cambridge, United States
Health care, Fintech Seed, Early stage venture, Late stage venture 25% 4
4 Matrix
Matrix invests in early-stage technology startups, with recent companies including Houmo.AI and Luma AI.
Cambridge, United States
Hardware, Artificial intelligence Seed, Early stage venture 32% 4
5 Engine Ventures
Engine Ventures backs companies developing technologies for scientific and engineering problems, with recent companies including Trener Robotics and Addis Energy.
Cambridge, United States
Artificial intelligence, Biotech 52% 2

Table 1. Venture investors in Cambridge, Massachusetts: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Venture investors in Cambridge, Massachusetts
One-time CSV
  • 35 firms, 28 with a website
  • 18 firm email addresses
  • 19 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-venture-investors-cambridge-massachusetts.csv35 rows × 15 columns
InvestorTypeLocationEmailPhone
Atlas VentureVenture capital firmCambridge, United States•••@atlasventure.com857 20•••
Founder CollectiveVenture capital firmCambridge, United States•••@foundercollective.com(617) •••
F-PrimeVenture capital firmCambridge, United States•••@fprimecapital.com
AccompliceFamily officeCambridge, United States•••@accomplice.co617-58•••
SBXiVenture capital firmCambridge, United States•••@sbxi.com
Sanofi VenturesCorporate venture armCambridge, United States•••@gmail.com+1 617•••
E14 FundMicro VC fundCambridge, United States•••@e14fund.com+1 617•••
Flint CapitalVenture capital firmCambridge, United States•••@flintcap.com

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-stage-venture-investors-cambridge-massachusetts-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
Atlas VentureB••• B•••Partnerb•••@atlasventure.comIn the CSV
MatrixD••• S•••General Partnerd•••@matrix.vcIn the CSV
Founder CollectiveA••• H•••General Partnera•••@foundercollective.comIn the CSV
F-PrimeS••• J•••General Partner and Co-Founder, Investing in AI Native Software s•••@fprimecapital.comIn the CSV
AccompliceS••• A••• D•••Operating Partners•••@accomplice.coIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

35
Investors
18
With email
19
With phone
12
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Venture investors in Cambridge, Massachusetts

28 of 35, most investments first
28 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Atlas Venture Venture capital firm Cambridge, United States Health care, Biotech Diagonal Therapeutics 1 638 179 199 •••@atlasventure.com 857 20••• In the CSV
2 Matrix Venture capital firm Cambridge, United States Hardware, Artificial intelligence Houmo.AI, Ampersand, Outset 4 585 190 151 (617) ••• In the CSV
3 Founder Collective Venture capital firm Cambridge, United States Artificial intelligence, Commerce Baselayer, WHOOP, Ownwell 5 543 35 161 •••@foundercollective.com (617) ••• In the CSV
4 F-Prime Venture capital firm Cambridge, United States Health care, Fintech T-Therapeutics, Albert Invent, Immuneel Therapeutics 4 540 133 113 •••@fprimecapital.com In the CSV
5 Accomplice Family office, Venture capital firm Cambridge, United States Fintech, Artificial intelligence Veera 1 386 101 88 •••@accomplice.co 617-58••• In the CSV
6 Flagship Pioneering Venture capital firm Cambridge, United States Biotech, Health care Inari, Prologue Medicines, Quotient Therapeutics 288 104 72 617-86••• In the CSV
7 SR One Venture capital firm Cambridge, United States Biotech, Health care Asceneuron 214 69 69 (610) ••• In the CSV
8 SBXi Venture capital firm Cambridge, United States Health care, Hardware SPORO Health, XanderGlasses, Basalt Tech 196 0 6 •••@sbxi.com In the CSV
9 Sanofi Ventures Corporate venture arm Cambridge, United States Biotech, Health care i2o Therapeutics, Tisento Therapeutics, NGI 119 31 28 •••@gmail.com +1 617••• In the CSV
10 E14 Fund Micro VC fund Cambridge, United States Artificial intelligence, Hardware Ramona 1 112 12 11 •••@e14fund.com +1 617••• In the CSV
11 Flint Capital Venture capital firm Cambridge, United States Artificial intelligence, Hardware Bluebricks, Antidote Health, Nokod Security 101 36 18 •••@flintcap.com In the CSV
12 Mission BioCapital Venture capital firm Cambridge, United States Biotech, Health care Circle Pharma, Cloverleaf Bio, Integrated Biosciences 4 85 17 19 •••@missionbiocapital.com +1 617••• In the CSV
13 Safar Partners Private equity firm, Venture capital firm Cambridge, United States Biotech, Health care Gelmedix 1 85 17 7 •••@safar.partners (646) ••• In the CSV
14 HubSpot Ventures Corporate venture arm Cambridge, United States Artificial intelligence, Commerce Agency AI, Artisan AI, doola 64 12 8 •••@hubspot.com +1 888••• In the CSV
15 Converge Venture capital firm Cambridge, United States Artificial intelligence, Fintech Zenskar 1 55 4 8 (617) ••• In the CSV
16 MRL Ventures Fund Corporate venture arm, Venture capital firm Cambridge, United States Biotech, Health care InduPro 1 52 8 14 In the CSV
17 Rhapsody Venture Partners Venture capital firm Cambridge, United States Hardware, Artificial intelligence Polaris Electro-Optics 1 46 25 2 •••@rhapsodyvp.com In the CSV
18 Tectonic Ventures Venture capital firm Cambridge, United States Artificial intelligence, Hardware Marveri, Humatics, OmniML 43 3 4 In the CSV
19 Engine Ventures Venture capital firm Cambridge, United States Artificial intelligence, Biotech Trener Robotics, Addis Energy 2 42 22 1 •••@engineventures.com 617-54••• In the CSV
20 Action Potential Venture Capital Venture capital firm Cambridge, United States Health care Presidio Medical 30 5 3 (888) ••• In the CSV
21 Rivas Capital Venture capital firm Cambridge, United States Artificial intelligence, Biotech ReviveMed, Comgy 25 5 5 (857) ••• In the CSV
22 Yonjin Venture Venture capital firm Cambridge, United States 24 5 7 •••@yjventure.com (657) •••
23 Blue Haven Initiative Micro VC fund, Venture capital firm Cambridge, United States Fintech Umati Capital, SmartProcure 23 6 3 •••@bluehaveninitiative.com 857 24••• In the CSV
24 Joint Effects Venture capital firm Cambridge, United States Software Trident Digital, Authentic Vision 13 3 1 In the CSV
25 Gurnet Point Capital Private equity firm, Venture capital firm Cambridge, United States Health care, Artificial intelligence Fairtility, BEFORE Brands 12 9 2 •••@gurnetpointcapital.com 617-58••• In the CSV
26 Forma Prime Venture capital firm Cambridge, United States 4 0 1 In the CSV
27 EST Global Corporate venture arm Cambridge, United States Artificial intelligence, Hardware RAI, DR. PECKER 3 2 0 •••@estgrp.net +1 786••• In the CSV
28 EGI Capital Private equity firm, Venture capital firm Cambridge, United States 0 0 0 •••@egicapital.biz In the CSV

Table 2. Venture investors in Cambridge, Massachusetts: the first 28 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 35.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Founder Collective Cambridge, United States 5 119 Baselayer, WHOOP, Ownwell
2 F-Prime Cambridge, United States 4 75 T-Therapeutics, Albert Invent, Immuneel Therapeutics
3 Matrix Cambridge, United States 4 109 Houmo.AI, Ampersand, Outset
4 Mission BioCapital Cambridge, United States 4 8 Circle Pharma, Cloverleaf Bio, Integrated Biosciences
5 Engine Ventures Cambridge, United States 2 7 Trener Robotics, Addis Energy
6 E14 Fund Cambridge, United States 1 20 Ramona
7 Rhapsody Venture Partners Cambridge, United States 1 3 Polaris Electro-Optics
8 MRL Ventures Fund Cambridge, United States 1 3 InduPro
9 Converge Cambridge, United States 1 10 Zenskar
10 Safar Partners Cambridge, United States 1 4 Gelmedix
11 Accomplice Cambridge, United States 1 47 Veera
12 Atlas Venture Cambridge, United States 1 47 Diagonal Therapeutics

Table 3. Venture investors in Cambridge, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime 51 to 100 2022
Albert Invent Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. Artificial intelligence Oakland, United States Series B $55.0M 2026-10-13 $105.0M F-Prime 101 to 250 2022
Ampersand Ampersand provides integration infrastructure for enterprise AI agents and software applications. Artificial intelligence San Francisco, United States Series A $15.0M 2026-10-06 $19.7M Matrix 11 to 50 2022
Baselayer Baselayer automates risk assessment and fraud detection for financial and government institutions. Artificial intelligence New York, United States Series A $35.0M 2026-09-22 $82.0M Founder Collective 51 to 100 2024
Ramona Ramona develops high-throughput microscopy tools for biology labs. Artificial intelligence Durham, United States Series A $25.0M 2026-09-22 $59.7M E14 Fund 11 to 50 2017
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco, United States Series E $92.5M 2026-09-16 $300.0M Mission BioCapital 11 to 50 2012
Polaris Electro-Optics Polaris Electro-Optics develops integrated photonics for communications and computation. Hardware Broomfield, United States Series B $50.0M 2026-09-15 $63.2M Rhapsody Venture Partners 11 to 50 2021
Cloverleaf Bio Cloverleaf Bio develops an RNA therapeutic platform for oncology. Biotech New Haven, United States Seed $33.0M 2026-09-08 $33.0M Mission BioCapital 1 to 10 2023
InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Seattle, United States Series B $77.0M 2026-08-12 $162.0M MRL Ventures Fund 51 to 100 2022
Integrated Biosciences Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. Artificial intelligence Redwood City, United States Series A $68.4M 2026-08-05 $85.6M Mission BioCapital 11 to 50 2022

Table 4. Venture investors in Cambridge, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 397 78%
Artificial intelligence 97 19%
Hardware 86 17%
Health care 83 16%
Fintech 62 12%
Biotech 50 10%
Commerce 45 9%
Cybersecurity 39 8%
Education 19 4%
Energy 4 1%

Table 5. Venture investors in Cambridge, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Venture investors in Cambridge, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 2 7%
2010s 17 63%
2000s 4 15%
1980s 2 7%
1970s 1 4%
1940s 1 4%

Table 7. Venture investors in Cambridge, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many venture investors in Cambridge, Massachusetts are on the list?
35, in the file dated 16 November 2026. 12 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
18 of the 35 carry an email address in the download and 19 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 35 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 35 rows, 18 firm email addresses and 19 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 12 of the 18 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Venture investors in Cambridge, Massachusetts: 35 rows, CSV, $29 one-time.

At once: the CSV with 35 rows, 18 firm email addresses and 19 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 12 of the 18 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in Cambridge

Other stages in Cambridge

Venture investors elsewhere

Cite: FundingWatcher, 35 venture investors in Cambridge, Massachusetts, 16 November 2026. https://fundingwatcher.com/investors/stage/venture-investors/cambridge-massachusetts/